Open Access

Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression

  • Authors:
    • Maria Cristina Petralia
    • Emanuela Mazzon
    • Paolo Fagone
    • Luca Falzone
    • Placido Bramanti
    • Ferdinando Nicoletti
    • Maria Sofia Basile
  • View Affiliations

  • Published online on: July 12, 2019     https://doi.org/10.3892/etm.2019.7774
  • Pages: 2055-2062
  • Copyright: © Petralia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Post‑partum depression (PPD) occurs in approximately 20% of women usually early following child delivery. PPD represents an important unmet medical need as it is frequently underdiagnosed and, as the neurobiology of the disease is limitedly known, no pathogenic‑tailored approach is available and only symptomatic medications are used. In the present study, we carried out a DNA microarray analysis to evaluate the fluctuation of cytokines, cytokine receptors and chemokines during the preconception period, the 1st and 3th trimester of pregnancy and the early post‑partum period. The data demonstrated that, as compared to always‑depressed patients and euthymic controls, women who developed PPD exhibited significant fluctuations in the levels of different cytokines and cytokine receptors, primarily related to tumor necrosis factor (TNF) and interleukin (IL)18. These data emphasize the role of the immune system in PPD. However, additional studies aimed at evaluating if and how these functional modifications of the immune system during pregnancy are related to the development of PPD warranted to confirm our findings.

References

1 

Roomruangwong C, Anderson G, Berk M, Stoyanov D, Carvalho AF and Maes M: A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression. Prog Neuropsychopharmacol Biol Psychiatry. 81:262–274. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Roeleveld DM and Koenders MI: The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine. 74:101–107. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Zhang H-L, Zheng X-Y and Zhu J: Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 24:443–453. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Chakraborty S, Kubatzky KF and Mitra DK: An update on interleukin-9: From its cellular source and signal transduction to its role in immunopathogenesis. Int J Mol Sci. 20:21132019. View Article : Google Scholar

5 

Dujmovic I, Mangano K, Pekmezovic T, Quattrocchi C, Mesaros S, Stojsavljevic N, Nicoletti F and Drulovic J: The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy. J Neuroimmunol. 207:101–106. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Ayakannu R, Abdullah NA, Radhakrishnan AK, Lechimi Raj V and Liam CK: Relationship between various cytokines implicated in asthma. Hum Immunol. May 1–2019.(Epub ahead of print). doi: 10.1016/j.humimm.2019.04.018. View Article : Google Scholar : PubMed/NCBI

7 

Nicoletti F, Mancuso G, Cusumano V, Di Marco R, Zaccone P, Bendtzen K and Teti G: Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur J Immunol. 27:1580–1583. 1997. View Article : Google Scholar : PubMed/NCBI

8 

Conway TF, Hammer L, Furtado S, Mathiowitz E, Nicoletti F, Mangano K, Egilmez NK and Auci DL: Oral delivery of particulate transforming growth factor beta 1 and all-trans retinoic acid reduces gut inflammation in murine models of inflammatory bowel disease. J Crohn's Colitis. 9:647–658. 2015. View Article : Google Scholar

9 

Nicoletti F, Di Marco R, Patti F, Reggio E, Nicoletti A, Zaccone P, Stivala F, Meroni PL and Reggio A: Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clin Exp Immunol. 113:96–99. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Barcellini W, Rizzardi GP, Borghi MO, Nicoletti F, Fain C, Del Papa N and Meroni PL: In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: Lack of relationship with clinical disease activity. Lupus. 5:139–145. 1996. View Article : Google Scholar : PubMed/NCBI

11 

Raghupathy R: Pregnancy: Success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 13:219–227. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Christian LM, Franco A, Glaser R and Iams JD: Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun. 23:750–754. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Simpson W, Steiner M, Coote M and Frey BN: Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: A longitudinal study. Br J Psychiatry. 38:190–196. 2016. View Article : Google Scholar

14 

Karlsson L, Nousiainen N, Scheinin NM, Maksimow M, Salmi M, Lehto SM, Tolvanen M, Lukkarinen H and Karlsson H: Cytokine profile and maternal depression and anxiety symptoms in mid-pregnancy-the FinnBrain Birth Cohort Study. Arch Women Ment Health. 20:39–48. 2017. View Article : Google Scholar

15 

Meylan F and Siegel RM: TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology. Semin Immunopathol. 39:21–28. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Leff Gelman P, Mancilla-Herrera I, Flores-Ramos M, Saravia Takashima MF, Cruz Coronel FM, Cruz Fuentes C, Pérez Molina A, Hernández-Ruiz J, Silva-Aguilera FS, Farfan-Labonne B, et al: The cytokine profile of women with severe anxiety and depression during pregnancy. BMC Psychiatry. 19:1042019. View Article : Google Scholar : PubMed/NCBI

17 

Mehta D, Newport DJ, Frishman G, Kraus L, Rex-Haffner M, Ritchie JC, Lori A, Knight BT, Stagnaro E, Ruepp A, et al: Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med. 44:2309–2322. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Lobbestael J, Leurgans M and Arntz A: Inter-rater reliability of the structured clinical interview for DSM-IV axis I disorders (SCID I) and axis II disorders (SCID II). Clin Psychol Psychother. 18:75–79. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Richter P, Werner J, Heerlein A, Kraus A and Sauer H: On the validity of the Beck Depression Inventory. A review. Psychopathology. 31:160–168. 1998. View Article : Google Scholar : PubMed/NCBI

20 

Bobo WV, Angleró GC, Jenkins G, Hall-Flavin DK, Weinshilboum R and Biernacka JM: Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: Analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data. Hum Psychopharmacol. 31:185–192. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Usuda K, Nishi D, Okazaki E, Makino M and Sano Y: Optimal cut-off score of the Edinburgh Postnatal Depression Scale for major depressive episode during pregnancy in Japan. Psychiatry Clin Neurosci. 71:836–842. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Gustafsson M, Edström M, Gawel D, Nestor CE, Wang H, Zhang H, Barrenäs F, Tojo J, Kockum I, Olsson T, et al: Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment. Genome Med. 6:172014. View Article : Google Scholar : PubMed/NCBI

23 

Fagone P, Mazzon E, Cavalli E, Bramanti A, Petralia MC, Mangano K, Al-Abed Y, Bramati P and Nicoletti F: Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences. J Neuroimmunol. 322:46–56. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Mangano K, Cavalli E, Mammana S, Basile MS, Caltabiano R, Pesce A, Puleo S, Atanasov AG, Magro G, Nicoletti F, et al: Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis. J Cell Physiol. 233:4156–4165. 2018. View Article : Google Scholar : PubMed/NCBI

25 

Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F and Mangano K: Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis. Oncotarget. 9:8263–8277. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Fagone P, Muthumani K, Mangano K, Magro G, Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus. Immunology. 142:594–602. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Fagone P, Mazzon E, Mammana S, Di Marco R, Spinasanta F, Basile MS, Petralia MC, Bramanti P, Nicoletti F and Mangano K: Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing remitting multiple sclerosis to natalizumab treatment. Mol Med Rep. 20:678–684. 2019.PubMed/NCBI

28 

Nicoletti F, Mazzon E, Fagone P, Mangano K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange A, et al: Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF. J Neuroimmunol. 332:224–232. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Presti M, Mazzon E, Basile MS, Petralia MC, Bramanti A, Colletti G, Bramanti P, Nicoletti F and Fagone P: Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma. Oncol Lett. 16:2881–2886. 2018.PubMed/NCBI

30 

Fagone P, Caltabiano R, Russo A, Lupo G, Anfuso CD, Basile MS, Longo A, Nicoletti F, De Pasquale R, Libra M, et al: Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. Sci Rep. 7:445642017. View Article : Google Scholar : PubMed/NCBI

31 

Basile MS, Mazzon E, Russo A, Mammana S, Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti F, et al: Differential modulation and prognostic values of immune-escape genes in uveal melanoma. PLoS One. 14:e02102762019. View Article : Google Scholar : PubMed/NCBI

32 

Mangano K, Mazzon E, Basile MS, Di Marco R, Bramanti P, Mammana S, Petralia MC, Fagone P and Nicoletti F: Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. Oncotarget. 9:17951–17970. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Fagone P, Mangano K, Mammana S, Pesce A, Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, Lombardo GA, et al: Identification of novel targets for the diagnosis and treatment of liver fibrosis. Int J Mol Med. 36:747–752. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Fagone P, Nunnari G, Lazzara F, Longo A, Cambria D, Distefano G, Palumbo M, Nicoletti F, Malaguarnera L and Di Rosa M: Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. Antiviral Res. 131:66–73. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Born TL, Thomassen E, Bird TA and Sims JE: Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem. 273:29445–29450. 1998. View Article : Google Scholar : PubMed/NCBI

36 

Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, et al: Purification and characterization of the human interleukin-18 receptor. J Biol Chem. 272:25737–25742. 1997. View Article : Google Scholar : PubMed/NCBI

37 

Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, et al: MyD88-mediated signaling prevents development of adenocarcinomas of the colon: Role of interleukin 18. J Exp Med. 207:1625–1636. 2010. View Article : Google Scholar : PubMed/NCBI

38 

Lichtblau N, Schmidt FM, Schumann R, Kirkby KC and Himmerich H: Cytokines as biomarkers in depressive disorder: Current standing and prospects. Int Rev Psychiatry. 25:592–603. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Quak J, Doornbos B, Roest AM, Duivis HE, Vogelzangs N, Nolen WA, Penninx BW, Kema IP and de Jonge P: Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? Psychoneuroendocrinology. 45:202–210. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Teshigawara T, Mouri A, Kubo H, Nakamura Y, Shiino T, Okada T, Morikawa M, Nabeshima T, Ozaki N, Yamamoto Y, et al: Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms. J Affect Disord. 255:168–176. 2019. View Article : Google Scholar : PubMed/NCBI

41 

Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, et al: Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Acta Psychiatr Scand. 135:373–387. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Xu W, Xu Z, Huang L, Qin EQ, Zhang JL, Zhao P, Tu B, Shi L, Li WG and Chen WW: Transcriptome sequencing identifies novel immune response genes highly related to the severity of human adenovirus type 55 infection. Front Microbiol. 10:1302019. View Article : Google Scholar : PubMed/NCBI

43 

Dennis C-LE and Stewart DE: Treatment of postpartum depression, part 1: A critical review of biological interventions. J Clin Psychiatry. 65:1242–1251. 2004. View Article : Google Scholar : PubMed/NCBI

44 

Frieder A, Fersh M, Hainline R and Deligiannidis KM: Pharmacotherapy of postpartum depression: Current approaches and novel drug development. CNS Drugs. 33:265–282. 2019.PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Petralia, M.C., Mazzon, E., Fagone, P., Falzone, L., Bramanti, P., Nicoletti, F., & Basile, M.S. (2019). Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression. Experimental and Therapeutic Medicine, 18, 2055-2062. https://doi.org/10.3892/etm.2019.7774
MLA
Petralia, M. C., Mazzon, E., Fagone, P., Falzone, L., Bramanti, P., Nicoletti, F., Basile, M. S."Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression". Experimental and Therapeutic Medicine 18.3 (2019): 2055-2062.
Chicago
Petralia, M. C., Mazzon, E., Fagone, P., Falzone, L., Bramanti, P., Nicoletti, F., Basile, M. S."Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression". Experimental and Therapeutic Medicine 18, no. 3 (2019): 2055-2062. https://doi.org/10.3892/etm.2019.7774